Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phase2 Labs is a private U.S. clinical laboratory and diagnostics company focused on molecular infectious disease testing, toxicology, microbiology, and routine core lab services. The company operates a CLIA-certified, CAP-accredited laboratory and provides testing services to healthcare providers, nursing homes, and assisted living communities, with mobile phlebotomy and electronic medical record integration. Its menu includes respiratory pathogen testing, urine and wound microbiology, women's health and STI testing, toxicology, and standard chemistry, hematology, and coagulation assays. Rather than developing therapeutics, Phase2 Labs is a commercial-stage diagnostic services business supporting patient management and care delivery through laboratory testing and reporting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phase2 Labs.